Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Lennham discloses deuterated testosterone compound

Nov. 11, 2021

UBE-1099: a novel Keap1-Nrf2 PPI inhibitor for kidney disease

Nov. 11, 2021

HDAC8 targeting for treating AKI shows promise

Nov. 10, 2021

Spiny mice can regenerate damaged kidneys without fibrosis

Nov. 10, 2021

Effective attenuation of renal fibrosis with a potent HIPK2 inhibitor

Nov. 10, 2021

Beta2-integrins as potential targets for ANCA-mediated glomerulonephritis

Nov. 10, 2021

IL-33, a potential new therapeutic target for diabetic kidney disease

Nov. 10, 2021

New mouse model allows investigation of EP3 receptor function in the kidney tubule

Nov. 10, 2021

ADX-097 displays targeted complement inhibition in tissues

Nov. 9, 2021

L-WNK1 inhibition as novel therapeutic strategy for protection from glomerular injury

Nov. 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 14, 2025.
FDA shift from animal testing fuels organoid, organ-on-chip demand
BioWorld Science
The U.S. FDA’s decision to phase out animal testing for INDs is driving a new market of alternative, nonanimal testing technologies like organoids and...
Septerna joins a $2.2B obesity deal with Novo
BioWorld
In a deal that could top out at about $2.2 billion, Septerna Inc. is getting $200 million up front from Novo Nordisk A/S in a collaboration to develop oral...
AACR 2025: Induced proximity strategy, beyond degraders
BioWorld
Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...